TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 66 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $252,000 | -11.0% | 65,791 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $283,000 | -7.2% | 65,791 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $305,000 | -80.4% | 65,791 | -57.7% | 0.00% | -83.3% |
| Q4 2015 | $1,559,000 | +18.9% | 155,459 | -11.6% | 0.01% | +20.0% |
| Q3 2015 | $1,311,000 | -80.3% | 175,777 | +25.5% | 0.01% | -78.3% |
| Q2 2015 | $6,645,000 | +32.4% | 140,077 | +2.3% | 0.02% | +27.8% |
| Q1 2015 | $5,019,000 | +2.5% | 136,987 | +11.1% | 0.02% | +5.9% |
| Q4 2014 | $4,898,000 | +155.8% | 123,349 | +28.5% | 0.02% | +142.9% |
| Q3 2014 | $1,915,000 | +215.5% | 95,979 | +113.3% | 0.01% | +250.0% |
| Q2 2014 | $607,000 | +23.9% | 44,988 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $490,000 | -35.4% | 44,988 | -19.8% | 0.00% | -33.3% |
| Q4 2013 | $758,000 | – | 56,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |